Current Drug Targets
Title:Editorial: New Strategies and Applications for Drugs Targeting EGFR and c-Met
Volume: 15 Issue: 14
Author(s): E. Giovannetti and L.G. Leon
Affiliation:
Export Options
About this article
Cite this article as:
Giovannetti E. and Leon L.G., Editorial: New Strategies and Applications for Drugs Targeting EGFR and c-Met, Current Drug Targets 2014; 15 (14) . https://dx.doi.org/10.2174/1389450115666141107104844
DOI https://dx.doi.org/10.2174/1389450115666141107104844 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
45
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Recent Patents on Light Based Therapies: Photodynamic Therapy, Photothermal Therapy and Photoimmunotherapy
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Design, Synthesis and In-Vitro Cytotoxicity of Novel Platinum (II) Complexes with Phthalate as the Leaving Group
Letters in Drug Design & Discovery Nanomedicine: A New Frontier in Cancer Therapeutics
Current Drug Delivery Prognostic and Predictive Biomarkers in Cancer
Current Cancer Drug Targets The Phosphoinositide 3-Kinase Pathway in Human Cancer: Genetic Alterations and Therapeutic Implications
Current Genomics γ-Tocotrienol Induces Apoptosis in Human T Cell Lymphoma through Activation of Both Intrinsic and Extrinsic Pathways
Current Pharmaceutical Design Editorial: The Real Impact of Target Therapy in Cancer Patients: Between Hope and Reality
Current Cancer Drug Targets Carbon Nanotube: A Versatile Carrier for Various Biomedical Applications
Drug Delivery Letters α7 Nicotinic Acetylcholine Receptors: A Therapeutic Target in the Structure Era
Current Drug Targets TGF-beta Signaling in Cancer Treatment
Current Pharmaceutical Design An EJC Factor RBM8a Regulates Anxiety Behaviors
Current Molecular Medicine Adenovirus Mediated Herpes Simplex Virus-Thymidine Kinase/Ganciclovir Gene Therapy for Resectable Malignant Glioma
Current Gene Therapy Nanoparticles for Tumor Targeted Therapies and Their Pharmacokinetics
Current Drug Metabolism Oncolytic Viruses: The Best is Yet to Come
Current Cancer Drug Targets The Innate Immune System and Fever under Redox Control: A Narrative Review
Current Medicinal Chemistry Natural Products in Structure-Assisted Design of Molecular Cancer Therapeutics
Current Pharmaceutical Design In-Situ Hybridization as a Molecular Tool in Cancer Diagnosis and Treatment
Current Medicinal Chemistry Towards Understanding the Role of Cancer-Associated Inflammation in Chemoresistance
Current Pharmaceutical Design The Role of Pemetrexed Combined with Gemcitabine for Non-Small-Cell Lung Cancer
Current Drug Targets α7 Nicotinic Acetylcholine Receptor Subunit in Angiogenesis and Epithelial to Mesenchymal Transition
Current Drug Targets